Lawyers Adapt To Crop Of New FDA Pilots
One is a trial run of a voucher program meant to speed up the drug approval process. Another is an artificial intelligence-assisted scientific review program. A third involves a new path...To view the full article, register now.
Already a subscriber? Click here to view full article